Patent · US Active

TLR7/8 antagonists and uses thereof

US10544122B2 · kind B2 · utility

2Cited by
1References
4Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 10, 2019
Grant dateJan 28, 2020
Priority date—
Expiry dateJul 10, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D487/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds of Formula 1 and pharmaceutically acceptable compositions thereof are useful as TLR7/8 antagonists.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.